ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
4 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
2 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
1 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
14 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
14
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
3 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
5 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
3 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
25 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
25
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
5 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
7 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
2 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
3 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Presentation - Dermatology Drug Development Summit Europe
|
|
same1
|
38 |
20K |
6 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
38
|
20K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Presentation - Dermatology Drug Development Summit Europe
|
|
same1
|
38 |
20K |
4 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
38
|
20K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Presentation - Dermatology Drug Development Summit Europe
|
|
same1
|
38 |
20K |
23 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
38
|
20K
|
23
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Presentation - Dermatology Drug Development Summit Europe
|
|
same1
|
38 |
20K |
9 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
38
|
20K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
2 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
2 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
1 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
3 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
5 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
4 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
1 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
same1
|
13K |
4.7M |
9 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
13K
|
4.7M
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
same1
|
13K |
4.7M |
2 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
13K
|
4.7M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
same1
|
13K |
4.7M |
18 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
13K
|
4.7M
|
18
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
3 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
7 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
4 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
1K
|
291K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix receives A$6.87m R&D Tax Incentive Refund
|
|
same1
|
56 |
19K |
3 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
56
|
19K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix receives A$6.87m R&D Tax Incentive Refund
|
|
same1
|
56 |
19K |
5 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
56
|
19K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix receives A$6.87m R&D Tax Incentive Refund
|
|
same1
|
56 |
19K |
4 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
56
|
19K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
8 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1K
|
291K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
2 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
1 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1K
|
291K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
2 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
8 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
2 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
2 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
2 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
7 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
6 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
3 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
6 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
6 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
2 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
3 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
1K
|
291K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
0 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
1K
|
291K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
7 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
1K
|
291K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
same1
|
1K |
291K |
0 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
1K
|
291K
|
0
|
|